Market-consistent valuation of insurance liabilities by cost of capital

TL;DR

This paper presents a comprehensive, market-consistent framework for valuing insurance liabilities using dynamic replication and capital costs, aligning with Solvency II and IFRS 4, and provides recursive formulas and bounds for the valuation.

Contribution

It introduces a novel explicit framework for insurance liability valuation incorporating limited liability and risk capital costs, extending existing approaches like Solvency II.

Findings

Recursive valuation formulas derived for insurance liabilities.

Upper bounds on the liability value established.

Explicit calculations demonstrated through a simple example.

Abstract

This paper investigates market-consistent valuation of insurance liabilities in the context of, for instance, Solvency II and to some extent IFRS 4. We propose an explicit and consistent framework for the valuation of insurance liabilities which incorporates the Solvency II approach as a special case. The proposed framework is based on dynamic replication over multiple (one-year) time periods by a portfolio of assets with reliable market prices, allowing for "limited liability" in the sense that the replication can in general not always be continued. The asset portfolio consist of two parts: (1) assets whose market price defines the value of the insurance liabilities, and (2) capital funds used to cover risk which cannot be replicated. The capital funds give rise to capital costs; the main exogenous input of the framework is the condition on when the investment of the capital funds is acceptable. We investigate existence of the value and show that the exact calculation of the value has to be done recursively backwards in time, starting at the end of the lifetime of the insurance liabilities. The main question only partially considered in this paper is the uniqueness of the value. We derive upper bounds on the value and, for the special case of replication by risk-free one-year zero-coupon bonds, explicit recursive formulas for calculating the value. Valuation in Solvency II and IFRS 4 is based on representing the value as a sum of a "best estimate" and a "risk margin". In our framework, it turns out that this split is not natural. Nonetheless, we show that a split can be constructed as a simplification, and that it provides an upper bound on the value under suitable conditions. We illustrate the general results by explicitly calculating the value for a simple example.